No Association Observed Between Biosimilar Rituximab Exposure and Hypersensitivity Hospitalization
Recommended
No Association Observed Between Biosimilar Rituximab Exposure and Hypersensitivity Hospitalization
Findings of a two-cohort study identified that exposure to biosimilar rituximab in patients with non-Hodgkin lymphoma and chronic lymphoid leukemia at initiation, switch, or over time was not linked to hypersensitivity hospitalization compared to originator rituximab.
Access the full article to read more here.
<!-- BEGIN ADVERTSERVE CODE -->
<div id="mobile_block_ad_1"><script type="text/javascript">
var _avp = _avp || [];
_avp.push({ tagid: 'mobile_block_ad_1', alias: '/', type: 'banner', zid: 1669, pid: 0, onscroll: 0, inview: true, secure: true });
</script></div>
<!-- END ADVERTSERVE CODE -->